Literature DB >> 24849556

Relationship Between Hematocrit Level and Cardiovascular Risk Factors in a Community-Based Population.

Yuan-Ze Jin1, Dong-Han Zheng1, Zhi-Ying Duan1, Ying-Zi Lin1, Xue-Ying Zhang1, Jing-Ru Wang1, Shuo Han1, Guo-Feng Wang1, Yi-Jing Zhang1.   

Abstract

BACKGROUND: This study aimed to determine the relationship between hematocrit (HCT) levels and cardiovascular risk factors in a community-based population of middle-aged adults.
METHODS: From April 2011 to February 2012, a total of 1,884 middle-aged adults were selected from a community-based population in China. Blood and urine samples were collected for routine blood and urine tests, and measurement of plasma glucose and lipid levels. Baseline information including traditional cardiovascular risk factors was obtained by standard questionnaire to analyze. We evaluated the distribution of the HCT values for middle-aged adults with or without cardiovascular risk factors. There were 548 males and 1,336 females in this study. The mean age of all subjects was 54.7 ± 6.7 years. There were 1,209 subjects with risk factors and 675 without risk factors.
RESULTS: The HCT levels in subjects with risk factors were higher than those without risk factors (P = 0.005). According to a simplified tool for evaluation of the 10-year risk of ischemic cardiovascular diseases (CVDs) in Chinese populations, all subjects were divided into four groups: the ultralow-risk group (1,367, 72.6%), low-risk group (232, 12.3%), intermediate-risk group (201, 10.7%), and high-risk/ultrahigh-risk group (84, 4.4%). Compared with HCT levels in the ultralow-risk group, significant differences were found in the low-risk, intermediate-risk, and high-risk/ultrahigh-risk groups (all P < 0.05).
CONCLUSION: Our results indicate that elevated HCT levels may be positively associated with cardiovascular risk factors. Thus, the combination of HCT values and cardiovascular risk factors may enable early diagnosis of CVDs.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  cardiovascular diseases; community-based population; hematocrit; middle-aged adults; risk factors

Mesh:

Year:  2014        PMID: 24849556      PMCID: PMC6807177          DOI: 10.1002/jcla.21767

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  32 in total

Review 1.  Melatonin and circadian biology in human cardiovascular disease.

Authors:  Alberto Dominguez-Rodriguez; Pedro Abreu-Gonzalez; Juan J Sanchez-Sanchez; Juan C Kaski; Russel J Reiter
Journal:  J Pineal Res       Date:  2010-06-01       Impact factor: 13.007

2.  Optimal hematocrit: a Procrustean bed for maximum oxygen transport rate?

Authors:  Ares Pasipoularides
Journal:  J Appl Physiol (1985)       Date:  2012-06-07

Review 3.  Cardiovascular benefits in moderate increases of blood and plasma viscosity surpass those associated with lowering viscosity: Experimental and clinical evidence.

Authors:  B Y Salazar Vázquez; J Martini; A Chávez Negrete; A G Tsai; S Forconi; P Cabrales; P C Johnson; M Intaglietta
Journal:  Clin Hemorheol Microcirc       Date:  2010       Impact factor: 2.375

4.  Blood rheology effect of submaximal exercise on young subjects.

Authors:  Marco Romagnoli; Rafael Alis; Vladimir Martinez-Bello; Fabian Sanchis-Gomar; Rafael Aranda; Mari-Carmen Gómez-Cabrera
Journal:  Clin Hemorheol Microcirc       Date:  2014       Impact factor: 2.375

5.  Microcirculation and blood rheology in patients with cerebrovascular disorders.

Authors:  Irina A Tikhomirova; Anna O Oslyakova; Svetlana G Mikhailova
Journal:  Clin Hemorheol Microcirc       Date:  2011       Impact factor: 2.375

6.  Elevated hematocrit in nonalcoholic fatty liver disease: a potential cause for the increased risk of cardiovascular disease?

Authors:  Guolin Li; Hui Hu; Wang Shi; Ye Li; Li Liu; Yaqin Chen; Xiaofei Hu; Jun Wang; Jun Gao; Dazhong Yin
Journal:  Clin Hemorheol Microcirc       Date:  2012       Impact factor: 2.375

Review 7.  Gender differences in cardiovascular disease: hormonal and biochemical influences.

Authors:  Faustino R Pérez-López; Luis Larrad-Mur; Amanda Kallen; Peter Chedraui; Hugh S Taylor
Journal:  Reprod Sci       Date:  2010-06       Impact factor: 3.060

8.  Erythropoietic response and outcomes in kidney disease and type 2 diabetes.

Authors:  Scott D Solomon; Hajime Uno; Eldrin F Lewis; Kai-Uwe Eckardt; Julie Lin; Emmanuel A Burdmann; Dick de Zeeuw; Peter Ivanovich; Andrew S Levey; Patrick Parfrey; Giuseppe Remuzzi; Ajay K Singh; Robert Toto; Fannie Huang; Jerome Rossert; John J V McMurray; Marc A Pfeffer
Journal:  N Engl J Med       Date:  2010-09-16       Impact factor: 91.245

Review 9.  Endothelial dysfunction in glaucoma.

Authors:  Hemma Resch; Gerhard Garhofer; Gabriele Fuchsjäger-Mayrl; Anton Hommer; Leopold Schmetterer
Journal:  Acta Ophthalmol       Date:  2008-05-27       Impact factor: 3.761

10.  Hypogonadism in the aging male diagnosis, potential benefits, and risks of testosterone replacement therapy.

Authors:  Prasanth N Surampudi; Christina Wang; Ronald Swerdloff
Journal:  Int J Endocrinol       Date:  2012-03-14       Impact factor: 3.257

View more
  5 in total

Review 1.  Erythrocytosis Following Testosterone Therapy.

Authors:  Samuel J Ohlander; Bibin Varghese; Alexander W Pastuszak
Journal:  Sex Med Rev       Date:  2017-05-16

2.  Improved Erythrocyte Deformability Induced by Sodium-Glucose Cotransporter 2 Inhibitors in Type 2 Diabetic Patients.

Authors:  Minkook Son; Ye Sung Lee; A Ram Hong; Jee Hee Yoon; Hee Kyung Kim; Ho-Cheol Kang; Sung Yang
Journal:  Cardiovasc Drugs Ther       Date:  2020-09-04       Impact factor: 3.727

3.  Impact of hematocrit on measurements of the intrinsic brain.

Authors:  Zhen Yang; R Cameron Craddock; Michael P Milham
Journal:  Front Neurosci       Date:  2015-01-20       Impact factor: 4.677

4.  A hospital based retrospective study of factors influencing therapeutic leukapheresis in patients presenting with hyperleukocytic leukaemia.

Authors:  Yanxia Jin; Shishang Guo; Qin Cui; Sichao Chen; Xiaoping Liu; Yongchang Wei; Yunbao Pan; Liang Tang; Tingting Huang; Hui Shen; Guanghui Xu; Xuelan Zuo; Shangqin Liu; Hui Xiao; Fei Chen; Fayun Gong; Fuling Zhou
Journal:  Sci Rep       Date:  2018-01-10       Impact factor: 4.379

5.  Therapeutic Plateletpheresis in Patients With Thrombocytosis: Gender, Hemoglobin Before Apheresis Significantly Affect Collection Efficiency.

Authors:  Hongqiang Jiang; Yanxia Jin; Yufeng Shang; Guolin Yuan; Dandan Liu; Jianfang Li; Cong Wang; Lu Ding; Xiqin Tong; Shishang Guo; Fayun Gong; Fuling Zhou
Journal:  Front Med (Lausanne)       Date:  2021-12-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.